Qingdao Haier Biomedical Co.,Ltd (SHA:688139)

SHA:688139 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	654.33	901.23	1,269	951.78	774.39	1,849
Trading Asset Securities	792.04	877.25	651.14	2,024	2,130	408.03
Cash & Short-Term Investments	1,446	1,778	1,920	2,975	2,904	2,257
Cash Growth	-6.95%	-7.39%	-35.46%	2.45%	28.69%	-0.54%
Accounts Receivable	444.09	352.76	208.35	192.17	136.29	182.61
Other Receivables	7.72	8.56	7.47	3.99	32	20.38
Receivables	451.81	361.32	215.82	196.16	168.29	202.98
Inventory	303.03	334.74	248.02	270.55	345.75	247.95
Prepaid Expenses	-	0.14	2.56	1.21	0.41	0.97
Other Current Assets	405.89	177.77	149.21	45.19	38.23	25.36
Total Current Assets	2,607	2,652	2,536	3,489	3,457	2,734
Property, Plant & Equipment	907.18	915.18	862.22	802.08	464.13	343.6
Long-Term Investments	852.63	972.71	1,030	371.85	358.34	261.19
Goodwill	758.73	757.87	642.68	451.3	323.45	323.85
Other Intangible Assets	382.23	402.3	367.73	312.35	241.62	214.6
Long-Term Deferred Tax Assets	76.21	66.01	51.67	30.52	35.43	47.23
Long-Term Deferred Charges	5.9	6.72	5.69	5.46	0.5	1.27
Other Long-Term Assets	22.1	14.24	29.18	26.91	19.53	16.89
Total Assets	5,612	5,787	5,526	5,489	4,900	3,943
Accounts Payable	405.74	427.6	390.98	485.06	431.57	448.09
Accrued Expenses	231.16	228.65	235.15	245.6	196.05	184.35
Short-Term Debt	10.01	10.01	6.01	10.01	-	25
Current Portion of Leases	4.63	5.76	3.42	5.48	1.65	-
Current Income Taxes Payable	29.84	35.21	35.8	28.68	48.01	40.3
Current Unearned Revenue	88.35	151.98	111.81	232.84	362.05	247.82
Other Current Liabilities	127.55	163.2	158.51	176.81	104.17	98.8
Total Current Liabilities	897.28	1,022	941.66	1,184	1,144	1,044
Long-Term Leases	6.09	7.43	8.69	10.67	4.32	-
Long-Term Unearned Revenue	21.54	23.17	28.62	32.88	32.18	32.65
Long-Term Deferred Tax Liabilities	49.22	52.51	46.99	43.59	25.9	29.43
Other Long-Term Liabilities	69.58	63.81	59.75	69.03	55.18	51.65
Total Liabilities	1,054	1,169	1,086	1,341	1,261	1,158
Common Stock	317.95	317.95	317.95	317.95	317.07	317.07
Additional Paid-In Capital	1,980	1,977	1,987	1,995	1,913	1,876
Retained Earnings	2,215	2,219	2,015	1,751	1,309	584.29
Treasury Stock	-202.51	-140.2	-99.74	-98.07	-	-
Comprehensive Income & Other	-2.07	-2.69	10.37	53.89	84.34	-1.01
Total Common Equity	4,308	4,372	4,231	4,021	3,623	2,776
Minority Interest	250.39	246.59	209.25	127.71	15.95	8.64
Shareholders' Equity	4,558	4,618	4,440	4,148	3,639	2,785
Total Liabilities & Equity	5,612	5,787	5,526	5,489	4,900	3,943
Total Debt	30.73	23.2	18.11	26.15	5.97	25
Net Cash (Debt)	1,416	1,755	1,902	2,949	2,898	2,232
Net Cash Growth	-6.92%	-7.73%	-35.50%	1.76%	29.86%	-1.64%
Net Cash Per Share	4.48	5.55	6.00	9.28	9.12	6.85
Filing Date Shares Outstanding	313.16	314.48	315.68	316.49	317.07	317.07
Total Common Shares Outstanding	313.16	314.48	316.47	316.49	317.07	317.07
Working Capital	1,710	1,630	1,594	2,304	2,313	1,690
Book Value Per Share	13.76	13.90	13.37	12.70	11.43	8.75
Tangible Book Value	3,167	3,211	3,220	3,257	3,058	2,237
Tangible Book Value Per Share	10.11	10.21	10.18	10.29	9.64	7.06
Buildings	697.6	696.63	649.88	257.73	243.72	230.31
Machinery	337.23	333.52	284.75	240.79	151.04	122.68
Construction In Progress	115.35	95.03	70.33	389.34	130.96	32.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.